{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:56:48Z","timestamp":1792483008695,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T00:00:00Z","timestamp":1443484800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T00:00:00Z","timestamp":1443484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The aim of our study was to assess the feasibility of implementing a protocol for the use of magnesium sulfate to prevent cerebral palsy. This retrospective single-center study included all women with fetuses of gestational age &lt;33 weeks of gestation whose birth was planned or expected within 24\u2009hours from September 2011 to December 2012. They were to receive magnesium sulfate, administered intravenously as a 4-g bolus followed by a constant infusion of 1\u2009g per hour. If delivery had not occurred after 12\u2009hours and was no longer considered imminent, the infusion was to be discontinued. The study included 119 women, 81 (68.1%) of whom received magnesium sulfate. Among the latter, 71 (87.5%) gave birth within 24\u2009hours. The reasons treatment was not given were: omission by medical team (19\/38, 50%), urgent delivery (18\/38, 47.4%) and contraindication to treatment (1\/38, 2.6%). The mean gestational age at protocol implementation was 29.6 +\/\u2212 2.1 weeks. Maternal monitoring, especially at the onset of infusion, appeared suboptimal. No major maternal side effects were observed. Our study shows that implementing a protocol for prevention of cerebral palsy by magnesium sulfate is feasible in a tertiary obstetric center.<\/jats:p>","DOI":"10.1038\/srep14732","type":"journal-article","created":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T05:21:54Z","timestamp":1443504114000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Implementation of an antenatal magnesium sulfate protocol for fetal neuroprotection in preterm infants"],"prefix":"10.1038","volume":"5","author":[{"given":"Pierre-Emmanuel","family":"Bouet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Brun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Madar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Laure","family":"Baisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Courtay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9raldine","family":"Gascoin-Lachambre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigismond","family":"Lasocki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Sentilhes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,29]]},"reference":[{"key":"BFsrep14732_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2471\/BLT.08.062554","volume":"88","author":"S Beck","year":"2010","unstructured":"Beck, S. et al. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bulletin of the World Health Organization. 88, 31\u201338 (2010).","journal-title":"Bulletin of the World Health Organization."},{"key":"BFsrep14732_CR2","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1542\/peds.2007-1270","volume":"121","author":"M Yeargin-Allsopp","year":"2008","unstructured":"Yeargin-Allsopp, M. et al. Prevalence of cerebral palsy in 8-year-old children in three areas of the United States in 2002: a multisite collaboration. Pediatrics. 121, 547\u201354 (2008).","journal-title":"Pediatrics."},{"key":"BFsrep14732_CR3","unstructured":"Australian Cerebral Palsy Registrer Group: Report of the Australian Cerebral Palsy Register, Birth Years 1993\u20132006. Sydney (2013)."},{"key":"BFsrep14732_CR4","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/BF02723017","volume":"68","author":"G Gathwala","year":"2001","unstructured":"Gathwala, G. Neuronal protection with magnesium. Indian J Pediatr. 68, 417\u20139 (2001).","journal-title":"Indian J Pediatr."},{"key":"BFsrep14732_CR5","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ajog.2010.01.022","volume":"202","author":"I Burd","year":"2010","unstructured":"Burd, I., Breen, K., Friedman, A., Chai, J. & Elovitz, M. A. Magnesium sulfate reduces inflammation-associated brain injury in fetal mice. Am J Obstet Gynecol. 202, 292\u20139 (2010).","journal-title":"Am J Obstet Gynecol."},{"key":"BFsrep14732_CR6","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1177\/1933719113503410","volume":"21","author":"MA Lutgendorf","year":"2014","unstructured":"Lutgendorf, M. A. et al. Effect of dexamethasone administered with magnesium sulfate on inflammation-mediated degradation of the blood-brain barrier using an in vitro model. Reprod Sci. 21, 483\u201391 (2014).","journal-title":"Reprod Sci."},{"key":"BFsrep14732_CR7","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1067\/mob.2002.123544","volume":"186","author":"R Mittendorf","year":"2002","unstructured":"Mittendorf, R. et al. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. Am J Obstet Gynecol. 186, 1111\u20138 (2002).","journal-title":"Am J Obstet Gynecol."},{"key":"BFsrep14732_CR8","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1001\/jama.290.20.2669","volume":"290","author":"CA Crowther","year":"2003","unstructured":"Crowther, C. A., Hiller, J. E., Doyle, L. W. & Haslam, R. R. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. JAMA. 290, 2669\u201376 (2003).","journal-title":"JAMA."},{"key":"BFsrep14732_CR9","doi-asserted-by":"crossref","unstructured":"Magpie Trial Follow-up Study Collaborative Group. The Magpie Trial: a randomized trial comparing magnesium sulfate with placebo for pre-eclampsia. Outcome for children at 18 months. BJOG. 114, 289\u201399 (2007).","DOI":"10.1111\/j.1471-0528.2006.01165.x"},{"key":"BFsrep14732_CR10","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/j.1471-0528.2006.01162.x","volume":"114","author":"S Marret","year":"2007","unstructured":"Marret, S., Marpeau, L., Zupan-Simunek, V., Eurin, D. & L\u00e9v\u00eaque-Hellot, M. F. For PREMAG trial group. Magnesium sulphate given before very-preterm birth to protect infant brain: the randomized controlled PREMAG trial. BJOG. 114, 310\u20138 (2007).","journal-title":"BJOG."},{"key":"BFsrep14732_CR11","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1056\/NEJMoa0801187","volume":"359","author":"DJ Rouse","year":"2008","unstructured":"Rouse, D. J. et al. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med. 359, 895\u2013905 (2008).","journal-title":"N Engl J Med."},{"key":"BFsrep14732_CR12","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1097\/AOG.0b013e3181ae98c2","volume":"114","author":"MM Costantine","year":"2009","unstructured":"Costantine M. M. & Weiner S. J. Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis. Obstet Gynecol. 114, 354\u201364 (2009).","journal-title":"Obstet Gynecol."},{"key":"BFsrep14732_CR13","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists. Magnesium sulfate before anticipated preterm birth for neuroprotection. Obstet Gynecol. 115, 669\u201371 (2010).","DOI":"10.1097\/AOG.0b013e3181d4ffa5"},{"key":"BFsrep14732_CR14","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S1701-2163(16)34886-1","volume":"33","author":"L Magee","year":"2011","unstructured":"Magee, L., Sawchuck, D., Synnes, A. & von Dadelszen, P. SOGC clinical practice guidelines. Magnesium sulphate for fetal neuroprotection. J Obstet Gynaecol Can. 33(5), 516\u201329 (2011).","journal-title":"J Obstet Gynaecol Can."},{"key":"BFsrep14732_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ejogrb.2013.01.026","volume":"169","author":"C Vayssi\u00e8re","year":"2013","unstructured":"Vayssi\u00e8re, C. et al. Prolonged and post-term pregnancies: guidelines for clinical practice from the French College of Gynecologists and Obstetricians (CNGOF). Eur J Obstet Gynecol Reprod Biol. 169, 10\u201316 (2013).","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"BFsrep14732_CR16","unstructured":"French Society of Anaestesiologist and Intensive Care (SFAR). Multidisciplinary management of severe preeclampsia. Experts\u2019 guidelines. Ann Fr Anesth Reanim. 28(3), 275\u201381 (2009)."},{"key":"BFsrep14732_CR17","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1479-828X.2012.01434.x","volume":"52","author":"LL Ow","year":"2012","unstructured":"Ow, L. L., Kennedy, A., McCarthy, E. A. & Walker, S. P. Feasibility of implementing magnesium sulphate for neuroprotection in a tertiary obstetric unit. Aust N Z J Obstet Gynecol. 52, 356\u2013360 (2012).","journal-title":"Aust N Z J Obstet Gynecol."},{"key":"BFsrep14732_CR18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/AOG.0b013e31827c5cf8","volume":"121","author":"JG Gibbins","year":"2013","unstructured":"Gibbins, J. G., Browning, K. R., Lopes, V. V., Anderson, B. L. & Rouse, D. J. Evaluation of the clinical use of magnesium sulfate for cerebral palsy prevention. Obstet Gynecol. 121(2 Pt 1), 235\u201340 (2013).","journal-title":"Obstet Gynecol."},{"key":"BFsrep14732_CR19","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/ajo.12271","volume":"55","author":"YH Tan","year":"2014","unstructured":"Tan, Y. H. & Groom, K. M. A prospective audit of the adherence to a new magnesium sulphate guideline for the neuroprotection of infants born less than 30 weeks\u2019 gestation. Aust N Z J Obstet Gynaecol. 55, 90\u20133 (2014).","journal-title":"Aust N Z J Obstet Gynaecol."},{"key":"BFsrep14732_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0022-3476(83)80366-7","volume":"103","author":"LA Papile","year":"1983","unstructured":"Papile, L. A., Munsick-Bruno, G. & Schaefer, A. Relationship of cerebral intraventricular hemorrhage and early childhood neurologic handicaps. J Pediatr. 103, 273\u20137 (1983).","journal-title":"J Pediatr."},{"key":"BFsrep14732_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0166-4328(05)80189-5","volume":"49","author":"LS De Vries","year":"1992","unstructured":"De Vries, L. S., Eken, P. & Dubowitz, L. M. The spectrum of leukomalacia using cranial ultrasound. Behav Brain Res. 49, 1\u20136 (1992).","journal-title":"Behav Brain Res."},{"key":"BFsrep14732_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00000658-197801000-00001","volume":"187","author":"MJ Bell","year":"1978","unstructured":"Bell, M. J. et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Annals of surgery. 187, 1\u20137 (1978).","journal-title":"Annals of surgery."},{"key":"BFsrep14732_CR23","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1097\/SLA.0b013e31814855f2","volume":"246","author":"MJ Englesbe","year":"2007","unstructured":"Englesbe, M. J. et al. Seasonal variation in surgical outcomes as measured by the American College of Surgeons-National Surgical Quality Improvement Program (ACS-NSQIP). Ann Surg. 246(3), 456\u201362 (2007).","journal-title":"Ann Surg."},{"key":"BFsrep14732_CR24","unstructured":"Royal College of Obstetricians and Gynaecologists. The management of severe pre-eclampsia\/eclampsia; National Institute for Health and Clinical Excellence Antenatal Care. NICE clinical guideline 62. London: National Institute for Health and Clinical Excellence (2006)."},{"key":"BFsrep14732_CR25","doi-asserted-by":"crossref","unstructured":"Patient safety checklist: magnesium sulfate before anticipated preterm birth. Obstet Gynecol. 120, 432\u20133 (2012).","DOI":"10.1097\/AOG.0b013e318268054c"},{"key":"BFsrep14732_CR26","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 106: Intrapartum fetal heart rate monitoring: nomenclature, interpretation and general management principles. Obstet Gynecol. 114(1), 192\u2013202 (2009).","DOI":"10.1097\/AOG.0b013e3181aef106"},{"key":"BFsrep14732_CR27","first-page":"CD000025","volume":"11","author":"L Duley","year":"2010","unstructured":"Duley, L., Gulmezoglu, A. M., Henderson-Smart, D. J. & Chou, D. Magnesium sulphate and other anticonvulsivants for women with pre-eclampsia. Cochrane Database Syst Rev. 11, CD000025 (2010).","journal-title":"Cochrane Database Syst Rev."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep14732.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep14732","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep14732.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T11:11:39Z","timestamp":1672917099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep14732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,29]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12,7]]}},"alternative-id":["BFsrep14732"],"URL":"https:\/\/doi.org\/10.1038\/srep14732","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,29]]},"assertion":[{"value":"18 February 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14732"}}